
FDA Committee Votes to Lift Restrictions on Peptide Manufacturing Despite Safety Concerns
An FDA committee, stacked with Kennedy-appointed members, voted to lift restrictions on manufacturing four peptides for human use, despite lacking safety and efficacy data, with decisions on three more peptides pending.


















